Similar articles

• [New S3 guideline of DGVS for eradication of Helicobacter pylori--recommendations for routine general practice. Focus on the stomach bacterium].

  [No authors listed] [No authors listed] MMW Fortschr Med. 2009 May 28;151(22):48-9. MMW Fortschr Med. 2009. PMID: 19526970 German. No abstract available.
• The effectiveness of systemic eradication therapy against oral Helicobacter pylori.

  Bago I, Bago J, Plečko V, Aurer A, Majstorović K, Budimir A. Bago I, et al. J Oral Pathol Med. 2011 May;40(5):428-32. doi: 10.1111/j.1600-0714.2010.00989.x. Epub 2010 Dec 28. J Oral Pathol Med. 2011. PMID: 21198868
• Efficacy of azythromicin-based triple therapy for Helicobacter pylori infection: a retrospective study.

  Pellicano R, Astegiano M, Smedile A, Saracco G, Berrutti M, Morgando A, Fadda M, Repici A, Fagoonee S, Rizzetto M. Pellicano R, et al. Panminerva Med. 2008 Sep;50(3):259-60. Panminerva Med. 2008. PMID: 18927531 No abstract available.
• [New options for helicobacter pylori antibiotic treatment].

  Misselwitz B, Kaiser P, Bauerfeind P, Vavricka SR. Misselwitz B, et al. Dtsch Med Wochenschr. 2011 Jul;136(28-29):1479-84. doi: 10.1055/s-0031-1281539. Epub 2011 Jul 5. Dtsch Med Wochenschr. 2011. PMID: 21732262 Review. German.
• Helicobacter pylori eradication: role of individual therapy constituents and therapy duration.

  Qasim A, O'Morain CA, O'Connor HJ. Qasim A, et al. Fundam Clin Pharmacol. 2009 Feb;23(1):43-52. doi: 10.1111/j.1472-8206.2008.00635.x. Epub 2009 Jan 10. Fundam Clin Pharmacol. 2009. PMID: 19207543 Review.